Typ : |
Zeitung |
Internet-Link : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
Forschungsgruppen : |
San Francisco - Theravance Biopharma |
Autoren : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
Titel : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
Veröffentlichung : |
Current Ther Res ; 77: 105-110. 2015 |
|
Niveau von Beweisen : |
|
physikalische Stabilität : |
|
chemische Stabilität : |
|
andere Verfahren : |
|
Kommentare : |
Abbauprodukte identifiziert und quantifiziert |
|
Molekülverzeichnis
Telavancin hydrochloride
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|